| Products |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
| API & Intermediates |
Now Position:Home > Products > API & Intermediates < Anti-cancer API |
|
| Sunitinib(CAS:341031-54-7) |
 |
|
|
Product No.
|
|
TP1068C
|
|
Name
|
|
Sunitinib
|
|
Synonyms
|
|
Sutent; SU-11248; (Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-
ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide
|
|
Structure
|
|
|
|
Formula
|
|
C22H27FN4O2
|
|
Mol. Wt.
|
|
398.47
|
|
CAS Number
|
|
341031-54-7
|
|
Purity
|
|
>99%
|
|
|
|
|
|
|
